April 21, 2020

Schwendinger M et al. J Infect Dis 2020;jiaa121.

A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus

Schwendinger M et al. J Infect Dis 2020

Download publication

You might also be interested by

Infographics

Next-Generation Flow Cytometry Analysis with CellEngine™

January 31, 2023

Immune Monitoring

More info

CellTalk

Easy, Customized Autogating With CellEngine™

December 14, 2022

Immune Monitoring

More info